Haemonetics Inventory 2010-2025 | HAE

Haemonetics inventory from 2010 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.
Haemonetics Annual Inventory
(Millions of US $)
2025 $365
2024 $317
2023 $259
2022 $293
2021 $323
2020 $270
2019 $194
2018 $161
2017 $177
2016 $187
2015 $211
2014 $198
2013 $184
2012 $117
2011 $84
2010 $80
2009 $77
Haemonetics Quarterly Inventory
(Millions of US $)
2025-03-31 $365
2024-12-31 $360
2024-09-30 $382
2024-06-30 $374
2024-03-31 $317
2023-12-31 $304
2023-09-30 $286
2023-06-30 $289
2023-03-31 $259
2022-12-31 $256
2022-09-30 $255
2022-06-30 $278
2022-03-31 $293
2021-12-31 $306
2021-09-30 $323
2021-06-30 $327
2021-03-31 $323
2020-12-31 $300
2020-09-30 $305
2020-06-30 $295
2020-03-31 $270
2019-12-31 $254
2019-09-30 $245
2019-06-30 $222
2019-03-31 $194
2018-12-31 $169
2018-09-30 $164
2018-06-30 $175
2018-03-31 $161
2017-12-31 $159
2017-09-30 $169
2017-06-30 $174
2017-03-31 $177
2016-12-31 $188
2016-09-30 $195
2016-06-30 $189
2016-03-31 $187
2015-12-31 $204
2015-09-30 $208
2015-06-30 $211
2015-03-31 $211
2014-12-31 $212
2014-09-30 $209
2014-06-30 $207
2014-03-31 $198
2013-12-31 $209
2013-09-30 $205
2013-06-30 $197
2013-03-31 $184
2012-12-31 $180
2012-09-30 $174
2012-06-30 $127
2012-03-31 $117
2011-12-31 $108
2011-09-30 $101
2011-06-30 $95
2011-03-31 $84
2010-12-31 $82
2010-09-30 $86
2010-06-30 $85
2010-03-31 $80
2009-12-31 $79
2009-09-30 $77
2009-06-30 $76
2009-03-31 $77
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.382B $1.361B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.034B 28.02
Boston Scientific (BSX) United States $152.131B 38.08
Stryker (SYK) United States $146.225B 30.58
EssilorLuxottica (ESLOY) France $128.281B 0.00
Medtronic (MDT) Ireland $111.581B 15.82
Haleon (HLN) United Kingdom $50.069B 28.51
Lonza Group Ag (LZAGY) Switzerland $49.244B 0.00
ResMed (RMD) United States $36.611B 27.50
GE HealthCare Technologies (GEHC) United States $32.762B 15.55
Agilent Technologies (A) United States $32.366B 21.10
Terumo (TRUMY) Japan $26.576B 34.52
Insulet (PODD) United States $22.320B 87.61
Koninklijke Philips (PHG) Netherlands $21.929B 15.76
Zimmer Biomet Holdings (ZBH) United States $18.186B 11.68
Baxter (BAX) United States $15.472B 11.55
Smith & Nephew SNATS (SNN) United Kingdom $13.270B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.449B 0.00
Bio-Rad Laboratories (BIO) United States $5.968B 20.77
Lantheus Holdings (LNTH) United States $5.558B 14.02
Prestige Consumer Healthcare (PBH) United States $4.181B 18.68
Perrigo (PRGO) Ireland $3.570B 9.05
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.271B 24.12
Envista Holdings (NVST) United States $3.166B 26.31
GN Store Nord (GNNDY) Denmark $2.180B 18.06
QuidelOrtho (QDEL) United States $2.022B 13.91
LeMaitre Vascular (LMAT) United States $1.884B 42.12
AtriCure (ATRC) United States $1.726B 0.00
Acuren (TIC) United States $1.272B 0.00
AdaptHealth (AHCO) United States $1.217B 12.36
Green Thumb Industries (GTBIF) United States $1.080B 24.29
Neogen (NEOG) United States $1.066B 13.64
Kestra Medical Technologies (KMTS) United States $1.025B 0.00
BioLife Solutions (BLFS) United States $1.021B 0.00
Phibro Animal Health (PAHC) United States $0.968B 12.38
InMode (INMD) Israel $0.906B 9.13
CeriBell (CBLL) United States $0.633B 0.00
Evolus (EOLS) United States $0.628B 0.00
Capricor Therapeutics (CAPR) United States $0.602B 0.00
Owens & Minor (OMI) United States $0.588B 4.88
Curaleaf Holdings (CURLF) Canada $0.565B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.553B 0.00
Valneva SE (VALN) France $0.525B 0.00
Surmodics (SRDX) United States $0.426B 0.00
Tilray Brands (TLRY) Canada $0.391B 0.00
VAREX IMAGING (VREX) United States $0.345B 12.68
SNDL (SNDL) Canada $0.339B 0.00
Aurora Cannabis (ACB) Canada $0.304B 54.10
SEMPERIT AG HLD (SEIGY) Austria $0.291B 0.00
Cerus (CERS) United States $0.264B 0.00
Viemed Healthcare (VMD) United States $0.260B 21.97
Cresco Labs (CRLBF) United States $0.260B 0.00
Sanara MedTech (SMTI) United States $0.257B 0.00
ZimVie (ZIMV) United States $0.254B 11.54
Canopy Growth (CGC) Canada $0.252B 0.00
Sanuwave Health (SNWV) United States $0.238B 0.00
OraSure Technologies (OSUR) United States $0.210B 0.00
TriSalus Life Sciences (TLSI) United States $0.202B 0.00
Biote (BTMD) United States $0.201B 5.65
Quanterix (QTRX) United States $0.200B 0.00
Brainsway (BWAY) Israel $0.195B 51.55
Omeros (OMER) United States $0.193B 0.00
Verano Holdings (VRNOF) United States $0.191B 0.00
High Tide (HITI) Canada $0.190B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.82
Organigram Global (OGI) Canada $0.175B 0.00
Exagen (XGN) United States $0.153B 0.00
FitLife Brands (FTLF) United States $0.136B 16.72
Vireo Growth (VREOF) United States $0.127B 0.00
Jin Medical (ZJYL) China $0.124B 0.00
MacroGenics (MGNX) United States $0.091B 0.00
Fonar (FONR) United States $0.090B 11.60
Veru (VERU) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
TerrAscend (TSNDF) Canada $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.084B 0.00
Agape ATP (ATPC) $0.073B 0.00
InterCure (INCR) Israel $0.067B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
Apyx Medical (APYX) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Jushi Holdings (JUSHF) United States $0.058B 0.00
Modular Medical (MODD) United States $0.044B 0.00
United-Guardian (UG) United States $0.038B 13.02
Nephros (NEPH) United States $0.036B 48.57
Rockwell Medical (RMTI) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Safety Shot (SHOT) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.019B 0.00
INLIF (INLF) $0.017B 0.00
Meihua Medical Technologies (MHUA) China $0.015B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00